You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. IGF OT IGF TARGETED NANOPARTICLE TREATMENT FOR BREAST CANCER STEM CELLS

    SBC: HYLAPHARM LLC            Topic: NCI

    Not Available

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  2. IGF OT IGF A STAGE BASED MOBILE INTERVENTION FOR SUBSTANCE USE DISORDERS IN PRIMARY CARE N DA POP SEPTEMBER FEBRUARY BASE AWARD

    SBC: Pro-Change Behavior Systems, Inc.            Topic: NIDA

    Not Available

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  3. IGF OT IGF VALIDATION OF MOBILE TECHNOLOGIES FOR CLINICAL ASSESSMENT

    SBC: Pro-Change Behavior Systems, Inc.            Topic: NCI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  4. IGF OT IGF FY IWIN NAVIGATING YOUR PATH TO WELL BEING SBIR PHASE II BASE AWARD PERIOD OF PERFORMANCE

    SBC: Pro-Change Behavior Systems, Inc.            Topic: NIDA

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  5. Multi-Source E-Beam kV X-Ray Tube for Image-Guided Radiotherapy

    SBC: Telesecurity Sciences, Inc.            Topic: 102

    DESCRIPTION provided by applicant This project will lead to the development of an optimized X ray tube with focal spots that can be placed immediately below and around the multi leaf collimator MLC of a radiotherapy system By steering a focused electron beam e beam on a series of cooled tungsten targets in sequence this system will provide a set of projection images that can be reco ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  6. Therapeutic Role of Inter-alpha Inhibitors in Wound Healing

    SBC: PROTHERA BIOLOGICS, INC.            Topic: NIAMS

    DESCRIPTION provided by applicant Wound healing is an intricately regulated process broadly characterized by phases of inflammation proliferation and remodeling Imbalances in any one of these phases can result in inadequate healing scar formation or in the development of chronic wounds such as diabetic ulcers Diabetic ulcers are responsible for the majority of lower extremity amputations ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  7. Novel, Ambulatory Cuff-less Non-invasive Arterial Blood Pressure Monitor

    SBC: Krisara Engineering            Topic: NHLBI

    DESCRIPTION provided by applicant The objective of this proposal is to complete the engineering development and testing of the Non Invasive Self calibrating Ambulatory Multi Modality NISAM blood pressure device to recognize hypertensive patients not currently identified using todayandapos s technology As well as providing better management of hypertensive patients by presenting a truer roun ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  8. Over-the-Wire Device for Immediate and Complete Peripheral Artery Occlusion

    SBC: Artio Medical, Inc            Topic: NHLBI

    DESCRIPTION provided by applicant Approximately peripheral artery embolization procedures are performed annually in the U S for a variety of clinical indications including stopping life threatening bleeding reducing blood flow to cancerous tumors and diverting blood away from arterial aneurysms arteriovenous fistulas and other vascular malformations Most of these procedures involve ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  9. Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophy

    SBC: STRYKAGEN CORPORATION            Topic: NIAMS

    DESCRIPTION provided by applicant Duchenne muscular dystrophy is caused by mutations in the dystrophin gene resulting in the loss of the dystrophin glycoprotein complex in skeletal muscle Loss of dystrophin results in reduced sarcolemmal integrity progressive muscle damage and compromised muscle function There is currently no cure and limited treatment options for DMD and all affected child ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  10. Medical Device to Improve Arteriovenous Fistula Maturation

    SBC: Flow Forward Medical, Inc.            Topic: 400

    DESCRIPTION provided by applicant This study aims to evaluate the in vivo effectiveness of the Arteriovenous Fistula Eligibility AFE System tm a small temporary wearable rotary blood pump system designed to rapidly and permanently dilate peripheral veins Successful commercialization of the AFE System would enable the creation of arteriovenous fistula AVF vascular access sites in hemodial ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government